Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr₹1,134 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,177 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr
Mar2020₹1,134 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr
21.33
Mar2020 ₹1,134 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,996.2 Cr 5.2% -18.5% 64.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,098.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹159,194.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,773.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹108,646.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,125.0 Cr 2% 1.5% 38% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

5.2%

-18.5%

64.8%

SENSEX

1%

-3.9%

5.1%


You may also like the below Video Courses